Cargando…

An Active Follow-up Strategy for Serological Suspects of Human African Trypanosomiasis with Negative Parasitology Set up by a Health Zone Team in the Democratic Republic of Congo

Background: The World Health Organization aims for the elimination of Human African Trypanosomiasis (HAT) as a public health problem by 2020 and for full elimination (absence of new cases) by 2030. One of strategies to achieve this is the active follow-up of all HAT serological suspects found during...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nkieri, Matthieu, Mbo, Florent, Kavunga, Papy, Nganzobo, Pathou, Mafolo, Titus, Selego, Chalet, Mwamba Miaka, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345707/ https://www.ncbi.nlm.nih.gov/pubmed/32260405 http://dx.doi.org/10.3390/tropicalmed5020053

Ejemplares similares

Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo
por: Crump, Ronald E., et al.
Publicado: (2021)

The Flipside of Eradicating a Disease; Human African Trypanosomiasis in a Woman in Rural Democratic Republic of Congo: A Case Report
por: Mudji, Junior, et al.
Publicado: (2019)

Trypanosomiasis Control, Democratic Republic of Congo, 1993–2003
por: Lutumba, Pascal, et al.
Publicado: (2005)

Communities’ Perception, Knowledge, and Practices Related to Human African Trypanosomiasis in the Democratic Republic of Congo
por: Kabanga, Charlie, et al.
Publicado: (2022)

Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of Congo
por: Davis, Christopher N., et al.
Publicado: (2021)

Impact of tiny targets on Glossina fuscipes quanzensis, the primary vector of human African trypanosomiasis in the Democratic Republic of the Congo
por: Tirados, Inaki, et al.
Publicado: (2020)

Parasitological, serological and molecular survey of camel trypanosomiasis in Somalia
por: Hassan-Kadle, Ahmed A., et al.
Publicado: (2019)

Predicting the impact of COVID-19 interruptions on transmission of gambiense human African trypanosomiasis in two health zones of the Democratic Republic of Congo
por: Aliee, Maryam, et al.
Publicado: (2021)

Feasibility of a dried blood spot strategy for serological screening and surveillance to monitor elimination of Human African Trypanosomiasis in the Democratic Republic of the Congo
por: Inocencio da Luz, Raquel, et al.
Publicado: (2021)

Cost of a new method of active screening for human African trypanosomiasis in the Democratic Republic of the Congo
por: Snijders, Rian, et al.
Publicado: (2020)

Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo
por: Das, Aatreyee M., et al.
Publicado: (2021)

Prevalence of Human African Trypanosomiasis in the Democratic Republic of the Congo
por: Mumba, Dieudonne, et al.
Publicado: (2011)

Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo
por: Snijders, Rian, et al.
Publicado: (2021)

Human African Trypanosomiasis Transmission, Kinshasa, Democratic Republic of Congo
por: Simo, Gustave, et al.
Publicado: (2006)

Human African Trypanosomiasis in a Rural Community, Democratic Republic of Congo
por: Lutumba, Pascal, et al.
Publicado: (2007)

Human African Trypanosomiasis in the Democratic Republic of the Congo: A Looming Emergency?
por: Hasker, Epco, et al.
Publicado: (2012)

Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and risk
por: Lumbala, Crispin, et al.
Publicado: (2015)

Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo
por: Kuemmerle, Andrea, et al.
Publicado: (2020)

Trypanosomiasis Relapse after Melarsoprol Therapy, Democratic Republic of Congo, 1982–2001
por: Pépin, Jacques, et al.
Publicado: (2005)

Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo
por: Rock, Kat S., et al.
Publicado: (2015)

Trypanosomiasis in the Congo
Publicado: (1904)

Identifying regions for enhanced control of gambiense sleeping sickness in the Democratic Republic of Congo
por: Huang, Ching-I, et al.
Publicado: (2022)

Village-scale persistence and elimination of gambiense human African trypanosomiasis
por: Davis, Christopher N., et al.
Publicado: (2019)

Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo
por: Antillon, Marina, et al.
Publicado: (2022)

Whose Elimination? Frontline Workers’ Perspectives on the Elimination of the Human African Trypanosomiasis and Its Anticipated Consequences
por: Falisse, Jean-Benoît, et al.
Publicado: (2020)

Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study
por: Kuemmerle, Andrea, et al.
Publicado: (2021)

Clinical, Parasitological, and Serological Follow-Up of Dogs with Sarcoptic Mange Treated Orally with Lotilaner
por: Moog, F., et al.
Publicado: (2021)

Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2–3 trial
por: Kande Betu Kumesu, Victor, et al.
Publicado: (2022)

Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo
por: Hoff, Nicole A, et al.
Publicado: (2019)

Cost-effectiveness of using a rapid diagnostic test to screen for human African trypanosomiasis in the Democratic Republic of the Congo
por: Bessell, Paul R., et al.
Publicado: (2018)

Modelling gambiense human African trypanosomiasis infection in villages of the Democratic Republic of Congo using Kolmogorov forward equations
por: Davis, Christopher N., et al.
Publicado: (2021)

Molecular identification of Plasmodium species in symptomatic children of Democratic Republic of Congo
por: Kavunga-Membo, Hugo, et al.
Publicado: (2018)

Epidemiology of circulating human influenza viruses from the Democratic Republic of Congo, 2015
por: Kavunga-Membo, Hugo, et al.
Publicado: (2018)

Examination of scenarios introducing rubella vaccine in the Democratic Republic of the Congo
por: Cheng, Alvan, et al.
Publicado: (2021)

Community empowerment through participation in a tsetse control project in the Democratic Republic of Congo
por: Vander Kelen, Catiane, et al.
Publicado: (2023)

Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC
por: Crump, Ronald E., et al.
Publicado: (2022)

Performance of the SD BIOLINE® HAT rapid test in various diagnostic algorithms for gambiense human African trypanosomiasis in the Democratic Republic of the Congo
por: Lumbala, Crispin, et al.
Publicado: (2017)

Acute flaccid paralysis surveillance indicators in the Democratic Republic of Congo during 2008-2014
por: Membo, Hugo Kavunga, et al.
Publicado: (2016)

Challenges in the Diagnostic Performance of Parasitological and Molecular Tests in the Surveillance of African Trypanosomiasis in Eastern Zambia
por: Mulenga, Gloria M., et al.
Publicado: (2021)

Trypanosome spliced leader RNA for diagnosis of acoziborole treatment outcome in gambiense human African trypanosomiasis: A longitudinal follow-up study
por: Ngay Lukusa, Ipos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4lhr46r6rkjur6tku98p0h1f6c